Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)
TipRanksApr 10 17:40
Needham: Reiterates that Sight Sciences (SGHT.US) holds the rating.
Zhitong FinanceApr 10 17:30
Sight Sciences Analyst Ratings
BenzingaApr 10 17:23
Sight Sciences Analyst Ratings
BenzingaMar 8 23:46
Stifel Maintains Buy on Sight Sciences, Raises Price Target to $7
BenzingaMar 8 23:47
Sight Sciences (SGHT) Receives a Hold From Piper Sandler
TipRanksMar 8 20:47
Needham Remains a Hold on Sight Sciences (SGHT)
TipRanksMar 8 18:40
Analysts Conflicted on These Healthcare Names: RAPT Therapeutics (RAPT), Eli Lilly & Co (LLY) and Sight Sciences (SGHT)
TipRanksMar 8 18:41
Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Integer Holdings (ITGR) and Pacific Biosciences (PACB)
TipRanksFeb 16 20:30
Needham Remains a Hold on Sight Sciences (SGHT)
TipRanksJan 9 19:05
Needham Remains a Hold on Sight Sciences (SGHT)
TipRanksDec 29, 2023 01:35
Morgan Stanley Maintains Equal-Weight on Sight Sciences, Raises Price Target to $4
BenzingaDec 4, 2023 20:47
Sight Sciences Analyst Ratings
BenzingaDec 4, 2023 20:46
Reevaluation of Sight Sciences' Financial Performance Amid Q3 Results and Reimbursement Uncertainty: A Hold Rating and Lowered Price Target
TipRanksNov 14, 2023 08:48
Stifel Nicolaus Remains a Buy on Sight Sciences (SGHT)
TipRanksNov 13, 2023 10:05
Sight Sciences Analyst Ratings
BenzingaNov 9, 2023 05:34
Piper Sandler Sticks to Their Hold Rating for Sight Sciences (SGHT)
TipRanksOct 13, 2023 18:36
Piper Sandler Reaffirms Their Hold Rating on Sight Sciences (SGHT)
TipRanksSep 25, 2023 18:55
Sight Sciences Analyst Ratings
BenzingaSep 18, 2023 22:48
Citigroup Maintains Neutral on Sight Sciences, Lowers Price Target to $4
BenzingaSep 15, 2023 22:09
No Data
No Data